DEF 14AThe Ballot
Aclaris Therapeutics, Inc. files DEF 14A
Filed Apr 23, 2026 · 2mo ago · Accession 0001104659-26-047262
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- DEF 14A
- Filing date
- Apr 23, 2026
- Report date
- Jun 4, 2026
- Document
- acrs-20260604xdef14a.htm
- Size
- 2.6 MB